The global non-invasive prenatal testing market is growing at a significant rate, due to mounting occurrence of chromosomal abnormalities, mounting maternal age and introduction of advanced products. Different products contributed to the non-invasive prenatal testing market size. The market has witnessed high demand for consumables over the last few years due to repeated supplies of consumables as compare to instruments.

Request for a free sample copy of this research report at https://www.vynzresearch.com/healthcare/non-invasive-prenatal-testing-market/request-sample

On the basis of application the market is subdivided into microdeletion syndrome, trisomy, and others. Increasing occurrence of chromosomal abnormalities with mounting maternal age is the factor responsible for the growth of the trisomy segment.

The refining reimbursement scenario for NIPT, mounting occurrence of chromosomal abnormalities, Mounting average maternal age, and introduction of advanced products are the primary growth drivers for non-invasive prenatal testing market.

North America is the largest non-invasive prenatal testing market as in the region the occurrence of chromosomal abnormalities is increasing. Mounting maternal age, improved healthcare infrastructure, and boosting alertness programs are also up surging growth of the North American non-invasive prenatal testing market. Asia-Pacific is observed to witness fastest growth in the market, due to mounting healthcare expenditure.

Browse full research report description at https://www.vynzresearch.com/healthcare/non-invasive-prenatal-testing-market

Key players in the non-invasive prenatal testing market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe.

GE Healthcare, Perkinelmer, Inc., Koninklijke N.V., Qiagen, Pacific Biosciences of California, Inc., Agilent Technologies, Inc. and Beijing Genomics Institute are the key players offering non-invasive prenatal testing.

Source: VynZ Research